NASDAQ:MGNX

Macrogenics Stock Predictions

etoro logo Buy MGNX
*Your capital is at risk
$4.20
+0.150 (+3.70%)
At Close: Jun 03, 2026
Currently predicting for Thu, 4 Jun 2026

MGNX Prediction Chart

MGNX Predictions History

Latest community submissions for MGNX.
Predictor Target Session Target Price Result Direction Accuracy Score
Dec 2, 2024 $3.45 -3.90% $3.69 X 93.50% 0
Jan 17, 2024 $10.76 -1.42% $10.55 V 98.06% 1
Jan 17, 2024 $10.66 -2.27% $10.55 V 98.94% 2
Skagitqg Skagitqg Merchant
Jan 17, 2024 Bullish $10.55 X 0
JS JS Pro
Nov 9, 2022 $6.15 -2.54% $6.00 V 97.41% 1
Nov 9, 2022 $6.08 -3.69% $6.00 V 98.63% 2
Nov 9, 2022 $4.95 -21.58% $6.00 V 82.54% 1
Nov 9, 2022 Bearish $6.00 V 1
JS JS Pro
Apr 20, 2020 $6.93 -1.00% $7.00 X 99.00% 2
تراحيب العتيبي تراحيب العتيبي @D8AAD8B1D8A7D8ADD98AD8A8D8A7D984D8B9D8AAD98AD8A8D98A.135728
Apr 20, 2020 $10.45 +49.29% $7.00 X 50.71% 1
Click to get the best stock tips daily for free!
Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for MGNX with a full price path, not just a one-day call.
  • Price path
  • Approved predictor
  • 3-month horizon
ABOUT MACROGENICS
MacroGenics
MacroGenics, Inc., a biopharmaceutical company, develops and commercializes antibody-based therapeutics to treat cancer in the United States. Its approved product is MARGENZA (margetuximab-cmkb), a human epidermal growth factor receptor 2 (HER2) receptor antagonist indicated, in combination with chemotherapy, for the treatment of adult patients with metastatic HER2-positive breast cancer who have received two or more prior anti-HER2 regimens. The...
GOLDEN STAR
Ticker Change Signal Date
RUN
$12.83
18.86% May 06
GLBE
$31.61
5.35% May 05
SAP
$172.39
10.69% May 05
W
WCLD
$27.34
27.18% Apr 29
ADBE
$243.57
7.61% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE